Exploring thiazole conjugates as cholinesterase inhibitors for Alzheimer’s disease treatment
Future Medicinal Chemistry · 18.08.2026 · 18 (16) · 2187-2201
DOI: 10.1080/17568919.2026.2699679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 11.07.2026. Verfasst von Anchal Dabas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Delhi Technological University, Delhi, India. Hauptthemen laut MEDLINE: Thiazoles, Alzheimer Disease, Cholinesterase Inhibitors. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's Disease (AD), a major global health concern, is marked by memory loss and cognitive decline, especially in the elderly. Cholinergic hypothesis is one of the leading hypotheses toward the treatment of AD, prompting the development of cholinesterase (ChE) inhibitors. Acetylcholinesterase (AChE) remains a vital therapeutic target due to its role in enhancing acetylcholine levels and neural function. The natural products, synthetic analogs, and hybrid molecules have been evaluated as inhibitors of ChEs. Recent studies highlight thiazole-fused heterocyclic scaffolds and their derivatives as promising ChE inhibitors with neuroprotective potential. This article covers the synthesis of conjugates of thiazole with piperazine, benzimidazole, pyrazole, and other heterocyclic compounds, along with their potential as ChE inhibitors. This article will be useful to medicinal chemists and pharmaceutical industries to design and synthesize library of thiazole conjugates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Chemistry, Delhi Technological University, Delhi, India.
ORCID-Profile: Anchal Dabas, Parul Yadav, Ram Singh
Zitieren
APA
Dabas, A., Yadav, P., & Singh, R. (2026). Exploring thiazole conjugates as cholinesterase inhibitors for Alzheimer’s disease treatment. Future Medicinal Chemistry, 18(16), 2187-2201. https://doi.org/10.1080/17568919.2026.2699679
Vancouver
Dabas A, Yadav P, Singh R. Exploring thiazole conjugates as cholinesterase inhibitors for Alzheimer’s disease treatment. Future Medicinal Chemistry. 2026;18(16):2187-2201. doi:10.1080/17568919.2026.2699679
BibTeX
@article{Dabas2026,
author = {Dabas, Anchal and Yadav, Parul and Singh, Ram},
title = {Exploring thiazole conjugates as cholinesterase inhibitors for Alzheimer’s disease treatment},
journal = {Future Medicinal Chemistry},
year = {2026},
volume = {18},
number = {16},
pages = {2187--2201},
doi = {10.1080/17568919.2026.2699679}
}
EUVIMED